Product
Peg-Interferon alpha-2b
1 clinical trial
1 indication
Indication
Neurofibromatosis type 1Clinical trial
Medical Treatment of "High-Risk" Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical TherapiesStatus: Completed, Estimated PCD: 2017-04-01